802 studies found for:    Open Studies | "Insulin"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin
2 Recruiting Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia
Condition: Post-Transplant Glucocorticoid Induced Diabetes
Interventions: Drug: Neutral protamine hagedorn (NPH) insulin;   Drug: Regular human insulin or Insulin Aspart;   Drug: Insulin glargine
3 Recruiting Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Condition: Diabetes During Pregnancy
Interventions: Drug: NPH;   Drug: Insulin LISPRO;   Drug: Insulin glulisine
4 Recruiting Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation
Condition: Hyperglycemia
Interventions: Drug: Insulin lispro, Humalog (Eli Lilly) in insulin pump;   Drug: Human insulin isophane, Humulin N (Eli Lilly);   Other: Standard of care
5 Unknown  PK/PD Study of Intranasal Insulin in Type I Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Insulin;   Drug: Insulin LISPRO
6 Not yet recruiting Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
7 Recruiting Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin;   Drug: human insulin;   Drug: Insulin Glargine;   Drug: Insulin glulisine
8 Recruiting Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE;   Drug: NPH insulin (insulin isophane);   Drug: INSULIN GLULISINE;   Drug: Regular insulin
9 Unknown  Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
Conditions: Type 2 Diabetes;   Liver Cirrhosis
Interventions: Drug: Glargine & Glulisine;   Drug: Regular insulin;   Drug: NPH & regular insulin
10 Unknown  Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
Conditions: Type 1 Diabetes;   Hypoglycemia
Interventions: Drug: Evening only administration of insulin glargine;   Drug: Morning only administration of insulin glargine;   Drug: split dose insulin glargine
11 Recruiting The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
12 Unknown  Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Gliclazide MR and Insulin Glargine Injection;   Drug: Biosynthetic Human Insulin Injection
13 Recruiting Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine;   Drug: Insulin detemir
14 Unknown  The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: insulin glulisine;   Drug: insulin aspart
15 Unknown  Veterans Inpatient Insulin Study and Transition to Outpatient Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: NPH/Regular 70/30 mix;   Drug: insulin aspart protamine/insulin aspart 70/30 mix
16 Unknown  Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
Condition: Acute Coronary Syndrome
Interventions: Drug: glucose insulin potassium;   Drug: GIK and intensive insulin therapy
17 Not yet recruiting A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec/insulin aspart;   Drug: insulin aspart;   Drug: insulin detemir
18 Recruiting Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
Condition: Gestational Diabetes Mellitus
Interventions: Drug: Insulin;   Drug: Metformin, glyburide and insulin
19 Not yet recruiting Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin aspart (FIAsp);   Drug: insulin aspart;   Drug: insulin glargine
20 Recruiting The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial
Condition: Type 1 Diabetes
Interventions: Other: CSII (Insulin Pump) plus DAFNE;   Other: MDI (levermir® & quick acting insulin) plus DAFNE

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years